March 19th 2025Article
The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with bovine respiratory disease or mastitis and for control of pain from foot rot in cattle. A study determining the pharmacokinetics of a single dose of flunixin transdermal formulation in American bullfrogs used ultrahigh-pressure liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) to determine plasma flunixin concentrations.